Jaromir Sykora

1.7k total citations
26 papers, 1.0k citations indexed

About

Jaromir Sykora is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Jaromir Sykora has authored 26 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Immunology and 9 papers in Oncology. Recurrent topics in Jaromir Sykora's work include Cell death mechanisms and regulation (13 papers), Hepatitis B Virus Studies (6 papers) and interferon and immune responses (4 papers). Jaromir Sykora is often cited by papers focused on Cell death mechanisms and regulation (13 papers), Hepatitis B Virus Studies (6 papers) and interferon and immune responses (4 papers). Jaromir Sykora collaborates with scholars based in Germany, United Kingdom and Netherlands. Jaromir Sykora's co-authors include Henning Walczak, Ronald Koschny, Tom M. Ganten, Tobias L. Haas, Wolfgang Stremmel, Martin R. Sprick, Kerstin Herzer, Min Li‐Weber, Henning Schulze‐Bergkamen and Peter Büchler and has published in prestigious journals such as PLoS ONE, Hepatology and Biochemistry.

In The Last Decade

Jaromir Sykora

26 papers receiving 1000 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jaromir Sykora Germany 16 792 361 283 178 151 26 1.0k
A. Corey United States 14 715 0.9× 254 0.7× 306 1.1× 169 0.9× 110 0.7× 30 972
Katsuhiko Fujikawa Japan 13 631 0.8× 164 0.5× 250 0.9× 189 1.1× 204 1.4× 20 868
Midori Hayashida Japan 11 773 1.0× 244 0.7× 388 1.4× 136 0.8× 100 0.7× 15 1.1k
Florine Obrist France 14 449 0.6× 178 0.5× 335 1.2× 145 0.8× 162 1.1× 16 842
Hidemi Hayashi Japan 14 801 1.0× 234 0.6× 424 1.5× 107 0.6× 185 1.2× 29 1.2k
Yun Hee Kang South Korea 18 535 0.7× 258 0.7× 332 1.2× 212 1.2× 51 0.3× 44 1.0k
Jirun Peng China 15 494 0.6× 373 1.0× 247 0.9× 143 0.8× 93 0.6× 29 909
Ian A. Bettencourt United States 6 477 0.6× 462 1.3× 272 1.0× 454 2.6× 68 0.5× 9 1.0k
Claire Fabre France 19 752 0.9× 234 0.6× 444 1.6× 222 1.2× 86 0.6× 43 1.3k
Galina M. Kiriakova United States 10 380 0.5× 169 0.5× 310 1.1× 210 1.2× 54 0.4× 11 707

Countries citing papers authored by Jaromir Sykora

Since Specialization
Citations

This map shows the geographic impact of Jaromir Sykora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaromir Sykora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaromir Sykora more than expected).

Fields of papers citing papers by Jaromir Sykora

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaromir Sykora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaromir Sykora. The network helps show where Jaromir Sykora may publish in the future.

Co-authorship network of co-authors of Jaromir Sykora

This figure shows the co-authorship network connecting the top 25 collaborators of Jaromir Sykora. A scholar is included among the top collaborators of Jaromir Sykora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaromir Sykora. Jaromir Sykora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frankish, Jamie, Debayan Mukherjee, Erminia Romano, et al.. (2023). The CD40 agonist HERA-CD40L results in enhanced activation of antigen presenting cells, promoting an anti-tumor effect alone and in combination with radiotherapy. Frontiers in Immunology. 14. 1160116–1160116. 11 indexed citations
2.
Richards, David M., Viola Marschall, Christian J. Merz, et al.. (2019). HERA-GITRL activates T cells and promotes anti-tumor efficacy independent of FcγR-binding functionality. Journal for ImmunoTherapy of Cancer. 7(1). 191–191. 24 indexed citations
3.
Merz, Christian J., Jaromir Sykora, Viola Marschall, et al.. (2018). The Hexavalent CD40 Agonist HERA-CD40L Induces T-Cell–mediated Antitumor Immune Response Through Activation of Antigen-presenting Cells. Journal of Immunotherapy. 41(9). 385–398. 21 indexed citations
4.
Thiemann, Meinolf, David M. Richards, Michael Kluge, et al.. (2018). A Single-Chain-Based Hexavalent CD27 Agonist Enhances T Cell Activation and Induces Anti-Tumor Immunity. Frontiers in Oncology. 8. 387–387. 17 indexed citations
5.
Fleten, Karianne G., Viví Ann Flørenes, Lina Prasmickaite, et al.. (2016). hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma. Cell Death Discovery. 2(1). 16081–16081. 10 indexed citations
6.
Merz, Christian J., Jaromir Sykora, Oliver Hill, et al.. (2015). Neutralization of the CD95 ligand by APG101 inhibits invasion of glioma cells in vitro. Anti-Cancer Drugs. 26(7). 716–727. 20 indexed citations
7.
Gieffers, Christian, Michael Kluge, Christian J. Merz, et al.. (2013). APG350 Induces Superior Clustering of TRAIL Receptors and Shows Therapeutic Antitumor Efficacy Independent of Cross-Linking via Fcγ Receptors. Molecular Cancer Therapeutics. 12(12). 2735–2747. 94 indexed citations
8.
Koschny, Ronald, Ulf Hinz, Jaromir Sykora, et al.. (2013). Cytosolic and nuclear caspase-8 have opposite impact on survival after liver resection for hepatocellular carcinoma. BMC Cancer. 13(1). 532–532. 18 indexed citations
9.
Zimmermann, Anna, Ronald Koschny, Jaromir Sykora, et al.. (2013). Hepatocyte expression of TRAIL pathway regulators correlates with histopathological and clinical parameters in chronic HCV infection. Pathology - Research and Practice. 210(2). 83–91. 8 indexed citations
10.
Rizza, Stacey A., Kishore B. Challagundla, Sekar Natesampillai, et al.. (2011). TRAIL Dependent Fratricidal Killing of gp120 Primed Hepatocytes by HCV Core Expressing Hepatocytes. PLoS ONE. 6(11). e27171–e27171. 5 indexed citations
11.
Macher‐Goeppinger, Stephan, Sebastian Aulmann, Katrin E. Tagscherer, et al.. (2009). Prognostic Value of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (TRAIL) and TRAIL Receptors in Renal Cell Cancer. Clinical Cancer Research. 15(2). 650–659. 56 indexed citations
12.
Koschny, Ronald, Jaromir Sykora, Wolfgang Stremmel, et al.. (2009). Differential expression of the TRAIL/TRAIL-receptor system in patients with inflammatory bowel disease. Pathology - Research and Practice. 206(1). 43–50. 26 indexed citations
13.
Koschny, Ronald, Heidrun Holland, Jaromir Sykora, et al.. (2009). Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosis. Journal of Neuro-Oncology. 97(2). 171–185. 17 indexed citations
14.
Ganten, Tom M., Jaromir Sykora, Ronald Koschny, et al.. (2009). Prognostic significance of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in patients with breast cancer. Journal of Molecular Medicine. 87(10). 995–1007. 69 indexed citations
15.
Grund, Kerstin, Rezvan Ahmadi, Georg Gdynia, et al.. (2008). Troglitazone-mediated sensitization to TRAIL-induced apoptosis is regulated by proteasome-dependent degradation of FLIP and ERK1/2-dependent phosphorylation of BAD. Cancer Biology & Therapy. 7(12). 1982–1990. 13 indexed citations
16.
Koschny, Ronald, Tom M. Ganten, Jaromir Sykora, et al.. (2007). TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specific apoptosis within a therapeutic window. Hepatology. 45(3). 649–658. 102 indexed citations
17.
Thomas, Dierk, Ramona Bloehs, Ronald Koschny, et al.. (2007). Doxazosin induces apoptosis of cells expressing hERG K+ channels. European Journal of Pharmacology. 579(1-3). 98–103. 20 indexed citations
18.
Ganten, Tom M., Ronald Koschny, Tobias L. Haas, et al.. (2005). Proteasome Inhibition Sensitizes Hepatocellular Carcinoma Cells, But Not Human Hepatocytes, to TRAIL *. Hepatology. 42(3). 588–597. 142 indexed citations
19.
Ehemann, Volker, et al.. (2003). Flow cytometric detection of spontaneous apoptosis in human breast cancer using the TUNEL-technique. Cancer Letters. 194(1). 125–131. 45 indexed citations
20.
Strotmann, Jörg, Johann Bauersachs, Daniela Fraccarollo, et al.. (2002). Trauma induced by nontraumatic coronary devices and its impact on vascular reactivity and morphology. American Journal of Physiology-Heart and Circulatory Physiology. 283(6). H2356–H2362. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Corey Breakdown of academic impact, for papers by Katsuhiko Fujikawa Breakdown of academic impact, for papers by Midori Hayashida Breakdown of academic impact, for papers by Florine Obrist Breakdown of academic impact, for papers by Hidemi Hayashi Breakdown of academic impact, for papers by Yun Hee Kang Breakdown of academic impact, for papers by Jirun Peng Breakdown of academic impact, for papers by Ian A. Bettencourt Breakdown of academic impact, for papers by Claire Fabre Breakdown of academic impact, for papers by Galina M. Kiriakova
Rankless by CCL
2026